首页 | 本学科首页   官方微博 | 高级检索  
     


Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine
Authors:Fumihiko Sakai MD  PhD  Takao Takeshima MD  PhD  Yoshihisa Tatsuoka MD  PhD  Koichi Hirata MD  PhD  Sunfa Cheng MD  Yotaro Numachi MD  PhD  Cheng Peng PhD  Fei Xue MD  Daniel D. Mikol MD  PhD
Affiliation:1. Neurology, Saitama International Headache Center, Saitama, Japan;2. Headache Center, Department of Neurology, Tominaga Hospital, Osaka, Japan;3. Department of Neurology, Tatsuoka Neurology Clinic, Kyoto, Japan;4. Department of Neurology, Dokkyo Medical University, Tochigi, Japan;5. Global Development, Amgen Inc., Thousand Oaks, CA, USA;6. Research & Development, Amgen K.K., Tokyo, Japan;7. Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA, USA;8. Global Safety, Amgen Inc., Thousand Oaks, CA, USA
Abstract:
Keywords:efficacy  episodic migraine  erenumab  Japanese  long-term  safety
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号